Posts by Sharad Bijanki
The U.S. Supreme Court’s 2013 ruling in Association for Molecular Pathology v. Myriad Genetics changed the landscape of what is considered patentable material in the context …
is an Associate in Parker Poe’s Life Sciences Industry Team. Based in Atlanta, his patent practice involves all stages of litigation, including developing infringement, invalidity, and claim construction strategies. He has also drafted and filed multiple inter partes review petitions before the PTAB, serving as lead and backup counsel, and he dedicates a significant portion of his practice to patent prosecution matters before the USPTO.
For more information or to contact Sharad, please visit his Firm Profile Page.